BridgeBio Oncology (NASDAQ: BBOT) officer reports tax-withheld RSU share disposition
Rhea-AI Filing Summary
BridgeBio Oncology Therapeutics, Inc. principal accounting officer Marc Cobo reported a routine tax-related share disposition. On the vesting of restricted stock units, the company withheld 125 shares of Common Stock to cover his tax obligations, rather than selling them in the open market. Following this withholding, Cobo directly holds 5,306 shares of Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 125 shares
Net Sell
1 txn
Insider
Cobo Marc
Role
Principal Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 125 | $7.80 | $975.00 |
Holdings After Transaction:
Common Stock — 5,306 shares (Direct)
Footnotes (1)
- F1. Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
Key Figures
Tax-withheld shares: 125 shares
Price per share for withholding: $7.80 per share
Shares held after transaction: 5,306 shares
3 metrics
Tax-withheld shares
125 shares
Common Stock withheld to cover RSU tax obligations
Price per share for withholding
$7.80 per share
Value used for tax-withholding disposition
Shares held after transaction
5,306 shares
Direct Common Stock holdings following tax withholding
Key Terms
restricted stock units, tax withholding obligations, Common Stock, Form 4
4 terms
restricted stock units financial
"in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations"
Common Stock financial
"shares of the Issuer's Common Stock withheld by the Issuer"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"insider Form 4 data describing the reported transaction"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did BridgeBio Oncology Therapeutics (BBOT) insider Marc Cobo report on this Form 4?
Marc Cobo reported that 125 shares of Common Stock were withheld to cover tax obligations from vesting restricted stock units. This is a mechanical tax-withholding event, not an open-market trade, and reflects standard handling of equity compensation.
Was the BBOT Form 4 transaction by Marc Cobo an open-market stock sale?
No, the transaction was not an open-market sale. The company withheld 125 shares of Common Stock to satisfy Cobo’s tax withholding obligations on RSU vesting, according to the footnote, which describes a non-discretionary tax payment mechanism.
What does transaction code "F" mean in Marc Cobo’s BBOT Form 4 filing?
Transaction code "F" indicates shares were used to pay an exercise price or tax liability. Here, 125 Common Stock shares were withheld by the issuer to cover Cobo’s tax withholding obligations when his restricted stock units vested, rather than being sold on the market.
What role does insider Marc Cobo hold at BridgeBio Oncology Therapeutics (BBOT)?
Marc Cobo is identified as an officer of BridgeBio Oncology Therapeutics with the title Principal Accounting Officer. His Form 4 filing reports a tax-withholding share disposition related to RSU vesting, not a discretionary purchase or sale of company stock.